期刊文献+

PET-CT与组织病理学在肺部肿物诊断中的对比分析 被引量:4

Comparison of preoperative PET-CT and pathological analyses in diagnosis of pulmonary tumors
下载PDF
导出
摘要 目的:探讨^(18)F-脱氧葡萄糖正电子发射体层显像(^(18)F-FDG Positron emission tomography–computed tomogaprhy,^(18)F-FDG PET-CT)检查与组织病理学在可切除肺部肿物诊断中的一致性。方法 :回顾性纳入肺部肿物患者在术前PET-CT诊断和术后组织病理学诊断资料,对两种诊断方法在肺部肿物性质、纵隔淋巴结转移、肺门及肺内淋巴结转移等方面进行对比分析。结果:术前PET-CT与术后病理在肺肿物良恶性判断符合率为87.3%,一致性中等(κ=0.401,P<0.001),说明两种诊断方法在肺部肿物性质方面的结果差异无显著性(Mc Nemar检验结果P=0.508);术前PET-CT与术后病理在纵隔淋巴结转移符合率为85.9%,一致性中等(κ=0.697,P<0.001),两种诊断方法在纵隔淋巴结转移方面的结果差异无显著性(Mc Nemar检验结果 P=0.754);术前PET-CT与术后病理在肺门及肺内淋巴结转移符合率为77.4%,一致性中等(κ=0.523,P<0.001),两种诊断方法在肺门及肺内淋巴结转移方面的结果差异无显著性(Mc Nemar检验结果 P=0.454)。结论:术前PET-CT与组织病理学在肺部肿物诊断中有较好的一致性,在术式的选择提供具有一定指导意义的依据。 Objective To investigate the consistency in 18F-deoxyglucose positron emission tomography (18F-FDG PET-CT) examination and histopathological analyses in the diagnoses of resectable lung tumors. Methods Retrospective reviews over the clinical data of lung tumor patients by preoperative PET-CT diagnosis and postoperative histopathological diagnosis were conducted to investigate the effects of the two diagnostic methods in terms of lung tumor properties , mediastinal lymph node metastasis , and pulmonary hilar lymph node metastasis. Results The diagnoses by preoperative PET-CT was consistent in differentiation of non-malignancy and malignancy of pathologic lung tumors by 87.3%, at a medium level (κ = 0.401, P 〈 0.001). McNemar test showed P = 0.508, indicating the two diagnostic methods were insignificantly different in the diagnosis of pulmonary tumors. The preoperative PET-CT was consistent in the diagnosis of the metastasis of pathologic mediastinal lymph node by 85.9%, at a medium level (κ = 0.697, P 〈 0.001). McNemar test showed P =0.754, indicating no significant difference between the diagnostic methods. The preoperative PET-CT was consistent with postoperative pathological examinations in the differentiations of the metastasis of pulmonary and hilar lymph node by 77.4%, at a medium level (κ=0.523, P 〈 0.001). McNemar test showed P = 0.454, indicating the two diagnostic methods were no significantly different. Conclusion Preoperative PET-CT and histopathologic examinations may be consistent in lung tumor diagnosis , which provides a basis for a certain significance in the surgical options.
出处 《实用医学杂志》 CAS 北大核心 2016年第12期1938-1941,共4页 The Journal of Practical Medicine
基金 吴阶平医学基金会资助项目(编号:320.6799.15008)
关键词 肺部肿物 18F-FDG PET-CT 一致性 Pulmonary tumor 18F-FDG PET-CT Consistency
  • 相关文献

参考文献19

  • 1FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010,127(12) :2893-2917.
  • 2SCHMIDT-HANSEN M, BALDWIN DR, ZAMORA J. FDG- PET/CT imaging for mediastinal staging in patients with potentially resectable non-small cell lung cancer [J]. JAMA, 2015,313 (14) : 1465-1466.
  • 3SCHMIDT-HANSEN M, BALDWIN DR, HASLER E, et al. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer [ J ]. Coehrane Database Syst Rev, 2014,11 : CD009519.
  • 4OLLENBERGER GP. Staging of lung cancer with integrated PET-CT[ J]. N Engl J Med, 2004,350( 1 ) : 86-87.
  • 5AMBROSINI V, NICOLINI S, CAROLI P, et al. PET/CT imaging in different types of lung cancer: an overview [ J ]. Eur J Radiol, 2012,81 (5) : 988-1001.
  • 6汪敏,徐友平.CT结合PET/CT显像诊断孤立性肺结节误诊原因分析[J].实用医学杂志,2013,29(12):2005-2007. 被引量:10
  • 7GUPTA NC, TAMIM WJ, GRAEBER GG, et al. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging [J]. Chest, 2001,120(2) : 521-527.
  • 8CERFOLIO RJ, BRYANT AS, OHJA B, et al. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival[J]. J Thorac Cardiovasc Surg,2005,130( 1 ) : 151-159.
  • 9黄庆娟,李天女.PET/CT在肺癌诊断中的应用价值(综述)[J].南京医科大学学报(自然科学版),2010,30(1):64-68. 被引量:5
  • 10HARVEY ILl, PITZER G, NISSMAN DB, et al. PET/CT in the assessment of previously treated skull base malignancies [J]. Head Neck, 2010,32( 1 ) : 76-84.

二级参考文献19

共引文献47

同被引文献36

  • 1谭文勇,胡德胜.头颈部肿瘤颈部淋巴结分区指南——2013版更新介绍[J].肿瘤防治研究,2014,41(1):90-93. 被引量:9
  • 2ZHENG R,ZENG H,ZHANG S,et al.National estimates of cancer prevalence in China,2011[J].Cancer Lett,2016,370(1):33-38.
  • 3PAUL A,JEFFREY B.Stereotactic body radiation therapy for stage I non-small cell lung cancer[J].Thorac Surg Clin,2016,26(3):261-169.
  • 4SHINYA H,HIDEKAZU T,HIROAKI H.Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non -small cell lung cancer : Evaluation of mass -like fibrosis [J].Thoracic Cancer,2015,6(2):186-193.
  • 5JfiRfiMIE C,SfiBASTIEN T,BERNARD D,et al.Areas of high 18F -FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer[J].J Nuclear Med,2015,26(2);196-203.
  • 6MASAHIKO A,HIROYOSHI A,MARIKO S,et al.Impact of pretreatment whole -tumor perfusion computed tomography and 18F -fluorodeoxyglucose positron emission tomography/computed tomography measurements on local control of non-small cell lung cancer treated with stereotactic body radiotherapy [J].J Radia Res,2016,57(s1):1-8.
  • 7HIDEKAZU T,SHINYA H,HIROAKI H.Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy [J].Asia-Pacific Journal of Clinical Oncol,2016,12(1): e113-e117.
  • 8NA FF,WANG JW,LI C,et al.Primary tumor standardized uptake value measured on F18- Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non -small -cell lung cancer receiving radiotherapy : meta-analysis[J].Thorac Oncol.2014,9(6):834-42.
  • 9YOKO S,ATSUSHI N,HIROSHI 0,et al.Value of dual time point F -18 FDG -PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non -small cell lung cancer treated with stereotactic body radiation therapy [J].European Journal of Radiology,2012,81(11):3530-3534.
  • 10PIERRE L,ZSOLT U,PHILIPPE C,et al.FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy [J].Eur J Nucl Med Mol Imaging,2016,43(8):1453-1460.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部